Home to Stay Mobile App for Colorectal Surgery

November 18, 2024 updated by: Erin Kennedy, Mount Sinai Hospital, Canada

Home to Stay: an Integrated Monitoring System Using a Mobile App to Reduce Readmissions Following Colorectal Surgery

Background: Colorectal surgery includes surgery for colorectal cancer, inflammatory bowel disease and other benign diseases such as diverticulitis. In Canada, approximately 21,000 colorectal surgeries are performed each year. Patients undergoing colorectal surgery face high rates of unplanned hospital visits including readmission to hospital and Emergency Room (ER) visits. These unplanned hospital visits lead to significant distress and anxiety for patients and increased health care costs.

Research Aims: The goal is to evaluate the use of an integrated discharge monitoring system with a mobile application (app) to support colorectal surgery patients at home following discharge from hospital.

Methods: The study will include 3 hospitals across Canada. Patients will be assigned to either a control group or intervention group. Control group patients will receive standard follow up care after going home following surgery. Intervention group patients will be enrolled in an integrated discharge monitoring system using an app to monitor their progress at home following discharge after surgery. The main outcomes are to measure the number of patients with unplanned hospital visits within 30 days of discharge following surgery, the quality of patient recovery and confidence managing one's own health care. Patients are eligible if they are being discharge home after having elective colorectal surgery, are 18 years or older and speak and understand English or French. At the end of the study, the outcomes between the control group and intervention group will be compared to look for important differences.

Expected Outcomes: It is expected that the results of this study will show that the integrated discharge monitoring system will lead to a significant improvement in the quality of patient recovery and self-confidence with one's own health care, as well as significantly reduce the number of unplanned hospital visits for patients undergoing colorectal surgery in Canada.

Study Overview

Status

Recruiting

Intervention / Treatment

Detailed Description

Background: Patients undergoing colorectal surgery are vulnerable during their transition from hospital to home and face high rates of unplanned hospital visits including readmission to hospital and ER visits. Not only does this lead to significant distress for patients but also translates into significant health care costs. At a patient engagement meeting with patients from across Canada led by our group, one of the main themes that emerged was the patients' sense of abandonment upon discharge from hospital following surgery. Based on this feedback, our investigative team developed and pilot tested an integrated discharge monitoring system using a mobile application (app) to support patients following discharge from hospital after colorectal surgery. The results of this pilot work provided compelling data to suggest that this integrated discharge monitoring system was feasible, highly rated by patients and may lead to a considerable decrease in 30-day unplanned hospital visits.

Research Aims: Therefore, the aim of this study is to conduct a 3 year, randomized controlled trial (RCT) to evaluate the effectiveness of an integrated discharge monitoring system to support colorectal surgery patients at home following discharge.

Methods: A RCT will be implemented at 3 high volume colorectal surgery centres across Canada. The intervention is an integrated discharge monitoring system using an app that has been developed and pilot tested in partnership with SeamlessMD. The inclusion criteria for the study are: any patient being discharged home following elective colorectal surgery, 18 years or older and able to speak and understand English or French. The primary outcome for the study is 30-day unplanned hospital visits and the secondary outcomes include patient quality of recovery and self-efficacy with one's own health care. A sample size of 670 patients is planned and will provide an 80% power to detect a 30% reduction in 30-day unplanned hospital visits, assuming a baseline 30-day unplanned hospital visit rate of 27%, 0.05 Type 1 error rate and an 80% power.

Expected Outcomes: It is expected that the results of this trial will show that the integrated discharge monitoring system leads to a significant improvement in patient satisfaction in terms of quality of recovery and self-efficacy as well as a significant reduction in 30-day unplanned hospital visits and health care costs.

Study Type

Interventional

Enrollment (Estimated)

670

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

    • Ontario
      • Toronto, Ontario, Canada
        • Recruiting
        • Mount Sinai Hospital
        • Contact:
          • Selina Research Coordinator

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • any patient who is being discharged to home after undergoing elective colorectal surgery
  • 18 years or older
  • able to speak and understand English or French
  • provides informed consent

Exclusion Criteria:

  • post-operative admission less than 3 days
  • requiring discharge to rehabilitation centre to recover prior to being able to go home

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Health Services Research
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Intervention Group
The intervention group will receive the same usual care as the control group plus be enrolled in the integrated discharge monitoring system.
The app will be provided to patients in hospital on post-operative day 3. On the day of discharge, the patient will be emailed a "Daily Health Check" and receive subsequent "Daily Health Check" emails on Day 1-14, 21 and 30 days following discharge. The "Daily Health Check" is a tailored questionnaire to elicit their symptoms and status of post-operative recovery. After the patient has completed the "Daily Health Check", a "Daily Health Check Summary" is emailed to the patient that summarizes their responses and provides appropriate action recommendations based on their responses ranging from: (i) suggestions for educational modules, (ii) expect a call from your health care team in the next 24 hours, (iii) call your surgeon's office today or (iv) go to the nearest emergency room. The patient's "Daily Health Check" responses are displayed in real time on a secure website that automatically "red flags" extreme responses to alert the health care team to contact the patient by telephone.
Active Comparator: Control Group
The control group will receive usual follow up care that is currently provided at the 3 participating centres.
The app will be provided to patients in hospital on post-operative day 3. On the day of discharge, the patient will be emailed a "Daily Health Check" and receive subsequent "Daily Health Check" emails on Day 1-14, 21 and 30 days following discharge. The "Daily Health Check" is a tailored questionnaire to elicit their symptoms and status of post-operative recovery. After the patient has completed the "Daily Health Check", a "Daily Health Check Summary" is emailed to the patient that summarizes their responses and provides appropriate action recommendations based on their responses ranging from: (i) suggestions for educational modules, (ii) expect a call from your health care team in the next 24 hours, (iii) call your surgeon's office today or (iv) go to the nearest emergency room. The patient's "Daily Health Check" responses are displayed in real time on a secure website that automatically "red flags" extreme responses to alert the health care team to contact the patient by telephone.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
30-day unplanned hospital visit rate
Time Frame: 30 Days
Proportion of patients who are either readmitted to any hospital or present to the ER at any hospital in the first 30 post-operative days.
30 Days

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
patient quality of recovery
Time Frame: 4 weeks after hospital discharge
Quality of Recovery 15 (QoR-15) questionnaire administered to patients in both groups
4 weeks after hospital discharge
patient self-efficacy to manage one's own health care
Time Frame: 4 weeks after hospital discharge
Patient Activation Measure (PAM-13) administered to patients in both groups
4 weeks after hospital discharge

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Erin Kennedy, Mount Sinai Hospital

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

May 25, 2021

Primary Completion (Estimated)

March 1, 2026

Study Completion (Estimated)

December 1, 2026

Study Registration Dates

First Submitted

January 17, 2020

First Submitted That Met QC Criteria

January 17, 2020

First Posted (Actual)

January 22, 2020

Study Record Updates

Last Update Posted (Actual)

November 20, 2024

Last Update Submitted That Met QC Criteria

November 18, 2024

Last Verified

November 1, 2024

More Information

Terms related to this study

Other Study ID Numbers

  • 18-0200-E

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Colorectal Disorders

Clinical Trials on Mobile App

Subscribe